Rating History for Larimar Therapeutics (LRMR) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/5/2026 | Joseph Schwartz | New Coverage | Outperform (N/A) |
12.00 (N/A) |
3.47 (3.65) |
5.19% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/5/2026 | Joseph Schwartz | New Coverage | Outperform (N/A) |
12.00 (N/A) |
3.47 (3.65) |
5.19% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||